TPO and autoimmune thrombocytopenic purpura: In addition, approximately two-thirds of patients with ITP have plasma autoantibodies that are able to significantly inhibit MK maturation from TPO-treated CD34+ hematopoietic progenitor cells [36] and induce apoptosis [44] in vitro.